Authors: SEGAL P FEIG PU SCHERNTHANER G RATZMANN KP RYBKA J PETZINNA D BERLIN C

Citation: P. Segal et al., THE EFFICACY AND SAFETY OF MIGLITOL THERAPY COMPARED WITH GLIBENCLAMIDE IN PATIENTS WITH NIDDM INADEQUATELY CONTROLLED BY DIET ALONE, Diabetes care, 20(5), 1997, pp. 687-691

Authors: BISCHOFF H ANGERBAUER R BENDER J BISCHOFF E FAGGIOTTO A PETZINNA D PFITZNER J PORTER MC SCHMIDT D THOMAS G

Citation: H. Bischoff et al., CERIVASTATIN - PHARMACOLOGY OF A NOVEL SYNTHETIC AND HIGHLY-ACTIVE HMG-COA REDUCTASE INHIBITOR, Atherosclerosis, 135(1), 1997, pp. 119-130

Authors: SCHERNTHANER G FEIG P HANEFELD M PETZINNA D RAPTIS S RYBKA J STANDL E

Citation: G. Schernthaner et al., COMPARISON OF MIGLITOL AND METFORMIN IN NIDDM PATIENTS NOT RESPONDINGSUFFICIENTLY TO SULFONYLUREA, Diabetes, 45, 1996, pp. 445-445

Authors: SCHERNTAHNER G FEIG P HANEFELD M PETZINNA D RAPTIS S RYBKA J STANDL E

Citation: G. Scherntahner et al., COMPARISON OF MIGLITOL AND METFORMIN IN NIDDM NOT SUFFICIENTLY RESPONDING TO SULFONYLUREAS, Diabetes, 45, 1996, pp. 746-746

Authors: RATZMANN KP FEIG PU PETZINNA D RYBKA J SCHERNTHANER G SEGAL P

Citation: Kp. Ratzmann et al., TREATMENT OF NON-INSULIN-DEPENDENT DIABETES-MELLITUS - MIGLITOL VERSUS GLIBENCLAMIDE VERSUS PLACEBO, Diabetologia, 38, 1995, pp. 199-199